BE695604A - - Google Patents

Info

Publication number
BE695604A
BE695604A BE695604DA BE695604A BE 695604 A BE695604 A BE 695604A BE 695604D A BE695604D A BE 695604DA BE 695604 A BE695604 A BE 695604A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE695604A publication Critical patent/BE695604A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0036Galactans; Derivatives thereof
    • C08B37/0042Carragenan or carragen, i.e. D-galactose and 3,6-anhydro-D-galactose, both partially sulfated, e.g. from red algae Chondrus crispus or Gigantia stellata; kappa-Carragenan; iota-Carragenan; lambda-Carragenan; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C07D489/04Salts; Organic complexes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE695604D 1966-03-18 1967-03-16 BE695604A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR54024A FR5227M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1966-03-18 1966-03-18

Publications (1)

Publication Number Publication Date
BE695604A true BE695604A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1967-09-18

Family

ID=8604122

Family Applications (1)

Application Number Title Priority Date Filing Date
BE695604D BE695604A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1966-03-18 1967-03-16

Country Status (6)

Country Link
AT (1) AT279802B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE695604A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK115144B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR5227M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1183403A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL6704037A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK171716B1 (da) * 1982-03-12 1997-04-07 Pharmacia & Upjohn Ab Fremgangsmåde til fremstilling af et kompleks af carrageenan og emepronium, doxycyklin eller propranolol
AU565487B2 (en) * 1983-09-16 1987-09-17 Fisons Corporation Liquid prolonged release pharmaceutical formulations containing ionic constituents
US4762709A (en) * 1983-09-16 1988-08-09 Pennwalt Corporation Liquid prolonged release pharmaceutical formulations containing ionic constituents
US4898860A (en) * 1985-08-16 1990-02-06 New York University Anticonvulsant composition and method
US4694010A (en) * 1985-08-16 1987-09-15 New York University Anticonvulsant compositions and method
FR2640137A1 (fr) * 1988-12-08 1990-06-15 Texinfine Sa Systemes transporteurs de principes actifs lipophiles et leur procede d'obtention
EP0454044B1 (de) * 1990-04-25 1995-12-06 Hoechst Aktiengesellschaft Pharmakologische Zubereitung, enthaltend Polyelektrolytkomplexe in mikropartikulärer Form und mindestens einen Wirkstoff
IT1297461B1 (it) 1997-10-29 1999-12-17 Ciocca Maurizio Preparazione di compresse a rilascio controllato a base di complessi tra carragenano e farmaci basici solubili
US7101575B2 (en) 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
DE102004013637A1 (de) 2004-03-19 2005-10-13 Capsulution Nanoscience Ag Verfahren zur Herstellung von CS-Partikeln und Mikrokapseln unter Verwendung poröser Template sowie CS-Partikel und Mikrokapseln
FR2906687A1 (fr) * 2006-10-10 2008-04-11 Pierre Calleja Substrat pour la conservation et la distribution d'ingredients actifs pour animaux aquatiques

Also Published As

Publication number Publication date
AT279802B (de) 1970-03-25
NL6704037A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1967-09-19
GB1183403A (en) 1970-03-04
FR5227M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1967-08-14
DK115144B (da) 1969-09-08

Similar Documents

Publication Publication Date Title
FR5227M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT281852B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1534566A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1144366A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1111066A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE675626A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE675849A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE695517A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE695280A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE695056A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE694293A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE693858A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE693796A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE692936A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE692634A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE692609A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE689341A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE674987A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE675850A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE675084A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE675644A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE675641A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE675640A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE675173A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE675376A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)